Publications by authors named "A Conners"

Article Synopsis
  • Tumor immune infiltration and blood immune signatures are important for predicting outcomes in breast cancer, but their link to response from neoadjuvant chemotherapy (NAC) hasn't been well studied.
  • In a study of 126 breast cancer patients, various immune cell populations in their blood were analyzed to determine if these profiles could predict how well patients would respond to NAC.
  • The findings indicated that specific immune cell types (like myeloid cells in triple-negative and T cells in hormone receptor-positive breast cancer) correlated with treatment responses, while those in HER2-positive cancer showed no significant associations.
View Article and Find Full Text PDF

Purpose To develop a molecular breast imaging (MBI)-guided biopsy system using dual-detector MBI and to perform initial testing in participants. Materials and Methods The Stereo Navigator MBI Accessory biopsy system comprises a lower detector, upper fenestrated compression paddle, and upper detector. The upper detector retracts, allowing craniocaudal, oblique, or medial or lateral biopsy approaches.

View Article and Find Full Text PDF

Molecular breast imaging (MBI) is one of several options available to patients seeking supplemental screening due to mammographically dense breasts. Patient experience during MBI may influence willingness to undergo the test but has yet to be formally assessed. We aimed to assess patient comfort level during MBI, to compare MBI comfort with mammography comfort, to identify factors associated with MBI discomfort, and to evaluate patients' willingness to return for future MBI.

View Article and Find Full Text PDF

Background And Purpose: To evaluate the long-term outcome of accelerated partial breast irradiation utilizing intraoperatively placed applicator-based brachytherapy (ABB) in early-stage breast cancer.

Materials And Methods: From our prospective registry, 223 patients with pTis-T2, pN0/pN1mic breast cancer were treated with ABB. The median treatment duration including surgery and ABB was 7 days.

View Article and Find Full Text PDF

Molecular breast imaging (MBI) is used for various breast imaging indications. An MBI lexicon has been developed, although the likelihood of malignancy of the lexicon descriptors has not been assessed to our knowledge. The purpose of this article was to evaluate the PPV for malignancy of the MBI lexicon imaging descriptors.

View Article and Find Full Text PDF